Research desks at Ndtv Profit and 2 other desks backed 5 stocks for short-term gains over the coming weeks, reflecting a broadly bullish market view.
Ndtv Profit and 2 other registered desks issued 33 equity short term recommendations today, targeting gains over a 2 to 4 week horizon. The batch carries a bullish bias — 33 buys against 0 sells — covering 5 stocks.
JUBLPHARMA attracted 8 separate recommendations from registered analysts — Ndtv Profit issued a buy at ₹740 targeting ₹870 (stop ₹709); Ndtv Profit issued a buy at ₹718 targeting ₹870 (stop ₹709); Ndtv Profit issued a buy at ₹741 targeting ₹870 (stop ₹709); Ndtv Profit issued a buy at ₹739 targeting ₹870 (stop ₹709); Ndtv Profit issued a buy at ₹753 targeting ₹870 (stop ₹709); Ndtv Profit issued a buy at ₹752 targeting ₹870 (stop ₹709); Ndtv Profit issued a buy at ₹748 targeting ₹870 (stop ₹709); Ndtv Profit issued a buy at ₹763 targeting ₹870 (stop ₹709).
SOUTHWEST attracted 10 separate recommendations from registered analysts — Zee Business issued a buy at ₹244 targeting ₹285; Zee Business issued a buy at ₹243 targeting ₹285; Zee Business issued a buy at ₹240 targeting ₹290; Zee Business issued a buy at ₹240 targeting ₹285; Zee Business issued a buy at ₹241 targeting ₹285; Zee Business issued a buy at ₹241 targeting ₹290; Zee Business issued a buy at ₹238 targeting ₹285; Zee Business issued a buy at ₹238 targeting ₹290; Zee Business issued a buy at ₹233 targeting ₹285; Zee Business issued a buy at ₹233 targeting ₹290.
MEESHO attracted 3 separate recommendations from registered analysts — Ndtv Profit issued a buy at ₹189 targeting ₹212 (stop ₹181); Ndtv Profit issued a buy at ₹190 targeting ₹212 (stop ₹181); Ndtv Profit issued a buy at ₹191 targeting ₹212 (stop ₹181).
Also covered: DIVISLAB (₹7,388 → ₹7,527) via Ndtv Profit; PIDILITIND (₹1,603 → ₹1,690) via Cnbc Awaaz.
Short-term calls are designed to play out over two to four weeks. Quarterly results, FII flows, and sector rotation remain key variables during the holding period.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.